Cholinesterase inhibitors for dementia with Lewy bodies.

@article{Wild2003CholinesteraseIF,
  title={Cholinesterase inhibitors for dementia with Lewy bodies.},
  author={Richard N. Wild and Thomas W. Pettit and Alistair Burns},
  journal={The Cochrane database of systematic reviews},
  year={2003},
  volume={3},
  pages={
          CD003672
        }
}
BACKGROUND Dementia with Lewy bodies (DLB) was first described in 1983, and clinical diagnostic criteria were published in the early to mid 1990s. It has been suggested DLB may account for up to 15-25% of cases of dementia among people aged over 65, although autopsy suggests much lower rates. Characteristic symptoms are dementia, marked fluctuation of cognitive ability, early and persistent visual hallucinations and spontaneous motor features of Parkinsonism. Falls, syncope, transient… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 36 CITATIONS

Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review.

  • International journal of geriatric psychiatry
  • 2014
VIEW 11 EXCERPTS
CITES RESULTS
HIGHLY INFLUENCED

Management of the behavioral and psychological symptoms of dementia

  • Clinical interventions in aging
  • 2007
VIEW 2 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Similar Papers